Two BlueCross plans select TriZetto?s claims software

TriMed Staff | | Health Imaging | Practice Management
Blue Cross and Blue Shield of Kansas City (BCBSKC) and Blue Cross and Blue Shield of Rhode Island (BCBSRI) have chosen the TriZetto Group’s real-time patient liability and point-of-service claims adjudication software, Provider POS Direct.

The Provider POS Direct application will be hosted for BCBSRI in a TriZetto data center. The Provider POS Direct software can be integrated with provider information systems and core payor administrative systems. The software is built on service-oriented architecture (SOA), with internet browser capability, web services for HIPAA compliance and ease of interoperability with legacy applications, according to the Newport Beach, Calif.-based TriZetto.

TriMed Staff

Related Content

MRI accident has prompted the company that installed the scanner to issue a safety warning
Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.